Cart
sales@molnova.com
Secoxyloganin
CAS No. 58822-47-2
Secoxyloganin( —— )
Catalog No. M18858 CAS No. 58822-47-2
Secoxyloganin possesses a hepato-protective effect. Secoxyloganin possesses antibacterial activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 76 | In Stock |
|
| 10MG | 130 | In Stock |
|
| 25MG | 254 | In Stock |
|
| 50MG | 370 | In Stock |
|
| 100MG | 541 | In Stock |
|
| 200MG | 770 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSecoxyloganin
-
NoteResearch use only, not for human use.
-
Brief DescriptionSecoxyloganin possesses a hepato-protective effect. Secoxyloganin possesses antibacterial activity.
-
DescriptionSecoxyloganin possesses a hepato-protective effect. Secoxyloganin possesses antibacterial activity. Secoxyloganin has cytotoxic activity against UACC-62 cell line.Secoxyloganin possesses the perfect protective effect on PRRSV infected cell and with the minimum protection concentration of 6. 25 μg/mL.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetProstaglandin Receptor
-
RecptorAntifection
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number58822-47-2
-
Formula Weight404.36
-
Molecular FormulaC17H24O11
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (247.30 mM)
-
SMILESO=C(OC)C2=CO[C@@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H](C=C)[C@@H]2CC(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Liu HQ, Wang TL.[Chemical constituents from flower of Lonicera fragrantissima].Zhong Yao Cai. 2014 Aug;37(8):1383-5.
molnova catalog
related products
-
Rutin
Rutin, a flavonol glycoside found in many plants including buckwheat; tobacco; forsythia; hydrangea; viola, etc., which possesses healthy effects for human.
-
Tafluprost
Tafluprost, a prostaglandin analog, is the selective agonist of fluoroprostaglandin (FP) receptor PGF2α.Tafluprost showed significant IOP-lowering effects without any safety concerns in patients with various types of glaucoma and OH in daily clinical practice and tafluprost is highly effective in any therapeutic pattern.
-
DG-041
DG-041 is an antagonist of high affinity EP3 receptor (IC50s: 4.6 nM and 8.1 nM in the binding and FLIPR assay, respectively ).
